We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

BMG LABTECH

BMG LABTECH is a manufacturer of a wide range of dedicated and multi-mode microplate instruments ranging from single-... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

New Assay Improves Detection Of Deadly Prion Diseases

By LabMedica International staff writers
Posted on 28 Apr 2016
Print article
Image: The FLUOstar Omega microplate reader (Photo courtesy of BMG Labtech).
Image: The FLUOstar Omega microplate reader (Photo courtesy of BMG Labtech).
Transmissible spongiform encephalopathies (TSEs), or prion diseases, are a family of rare progressive, neurodegenerative illnesses that affect both humans and animals and TSE surveillance is important for public health and food safety.

Because TSEs have the potential of crossing from animals to humans, as seen with the spread of mad cow disease, or bovine spongiform encephalopathy (BSE), an advanced assay that offers better sensitivity than currently available tests for detecting a prion disease is essential.

Scientists at the Lethbridge Laboratory (AB, Canada) studied elk brains from animals suffering from chronic wasting disease, a prion disease that affects cervids, which are hoofed ruminant mammals in the deer family, as the model for the assay. Surveillance programs rely on highly sensitive diagnostic methods to detect infections early. Addressing the need to define steadfast analytical performance criteria for prion amyloid seeding assays (ASAs), they developed a method to measure prion protein conversion time (from normal cellular form to prion form) by a combination of statistical analyses to obtain a prion-detecting ASA with a known degree of confidence.

The timed prion seeding assay (tASA) is an in vitro method that mimics the conjectured mechanism of prion propagation in vivo. It is a conversion assay that uses recombinant prion-related protein as a substrate and detects conversion via changes in fluorescence. The team described time specifications for the assay to help avoid false-positive results (30 hours) or false-negative results in weakly positive samples (48 hours), as well as the number of replications necessary for adequate sensitivity (two to 12). The assay is analyzed on a FLUOstar Omega microplate reader (BMG Labtech, Ortenberg, Germany).

They compared the sensitivity of the new assay technique, the tASA to other currently available tests: two bioassays in laboratory rodents and three commercially available TSE rapid tests. The three regulatory-approved TSE rapid test platforms were the Prionics Check WESTERN (Thermo Fisher Scientific, Waltham, MA, USA); the Bio-Rad TeSeE enzyme-linked immunosorbent assay (ELISA, Hercules, CA, USA); and the IDEXX HerdChek CWD enzyme-linked immunoassay (EIA, IDEXX, Westbrook, ME, USA).

The investigators were able to define clear cut-off criteria, allowing determination of TSE-positive and TSE-negative states. Unlike TSE rapid tests, ASAs also have the potential to detect and measure TSE infection in blood, saliva, or urine. This would offer clinical advantages, such as the ability to sample blood instead of relying on more invasive tissue biopsy and to screen blood donations for contamination.

John G. Gray, MS, the lead author of the study said, “We found that the tASA was at least as sensitive as two rodent bioassays and up to 16 times more sensitive than three different TSE rapid tests. We believe this methodology represents the future for prion diagnostics, especially concerning human health, for example in screening blood donations.” The study will be published on April 8, 2016, in The Journal of Molecular Diagnostics.

Related Links:
Lethbridge Laboratory
BMG Labtech
Thermo Fisher Scientific
Bio-Rad Laboratories
IDEXX
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.